Press Releases
Warwick awarded £2.3 million to help develop cutting-edge technologies for cancer diagnosis and personalised treatment
Greg Clark, UK Secretary of State for Business, Energy and Industrial Strategy (BEIS), will confirm today (Tuesday 6 November) that UK Research and Innovation will invest £10 million in the PathLAKE project as part of the Industrial Strategy Challenge Fund. The University of Warwick has been awarded £2.3 million of the funding which will be used to create innovative solutions in digital pathology and Artificial Intelligence (AI) to speed up the time in which cancer is diagnosed and treated.
Six months of Herceptin could be as effective as 12 months for some women with HER2 positive breast cancer
Study that finds women with HER2 positive early-stage breast cancer taking Herceptin for six months could be as effective as 12 months in preventing relapse and death, and can reduce side effects, finds new research.
Oral drug treatment helps protect cancer patients from potentially deadly DVT and pulmonary embolism
Research from the University of Warwick indicates that taking a tablet a day can help treat cancer patients of a potentially deadly condition.
Light-activated cancer drugs without toxic side effects: fresh insight
Future cancer drugs that are activated by light and don’t cause the toxic side-effects of current chemotherapy treatments are closer to becoming a reality, thanks to new research made possible by the Monash Warwick Alliance, an intercontinental collaboration between the University of Warwick (UK) and Monash University (Australia).
Researchers call for improvement in collection of quality of life trial data
Researchers have recommended changes to international guidelines used in the development of clinical trials in an effort to gain information about the impact of the treatment on participating patients and their quality of life.
Talk to experts about the University of Warwick’s cancer research
People from across the region are being invited to spend the evening in conversation with some the University of Warwick’s cancer research team next week (Tuesday 30 January).